PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PYPD PolyPid Ltd.

Trading 03-24 12:01:54 EDT

4.16

+0.01

+0.24%

High4.22	Low4.03	Vol19.59K
Open4.19	D1 Closing4.15	Amplitude4.58%
Mkt Cap79.39M	Tradable Cap42.62M	Total Shares19.08M
T/O80.37K	T/O Rate0.19%	Tradable Shares10.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PYPD","market":"US","secType":"STK","nameCN":"PolyPid Ltd.","latestPrice":4.16,"timestamp":1774367918144,"preClose":4.15,"halted":0,"volume":19587,"delay":0,"changeRate":0.002409638554216816,"floatShares":10245500,"shares":19083200,"eps":-2.09,"marketStatus":"Trading","change":0.01,"latestTime":"03-24 12:01:54 EDT","open":4.19,"high":4.2199,"low":4.03,"amount":80366.851677,"amplitude":0.045759,"askPrice":4.2,"askSize":167,"bidPrice":4.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.09,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"listingDate":1593144000000,"exchange":"NASDAQ","adjPreClose":4.15,"postHourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.15,"latestTime":"16:10 EDT","volume":1,"amount":4.15,"timestamp":1774296605251,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.798969,"impliedVol":4.1057,"impliedVolPercentile":0.9767},"requestUrl":"/m/hq/s/PYPD/tweets","defaultTab":"tweets","newsList":[{"id":"2621996081","title":"PolyPid Ltd. CFO Jonathan Missulawin files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2621996081","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621996081?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:01","pubTimestamp":1774296109,"startTime":"0","endTime":"0","summary":"PolyPid said Chief Financial Officer Jonathan Missulawin filed an initial Form 3 reporting employee stock options covering 190,513 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL5NsC32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2621080727","title":"PolyPid Director Joseph BenAmram Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2621080727","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621080727?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:04","pubTimestamp":1774267463,"startTime":"0","endTime":"0","summary":"Joseph BenAmram, a director at PolyPid, filed an initial statement of beneficial ownership reporting stock options covering 14,440 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL8KjWB0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2620264228","title":"PolyPid Director Brooke Story Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264228","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264228?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:05","pubTimestamp":1773864310,"startTime":"0","endTime":"0","summary":"PolyPid reported an initial statement of beneficial ownership by director Brooke Story. Brooke Story reported direct ownership of stock options covering 17,456 ordinary shares. The options have an exercise price of 4.01 USD per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL84GrGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2620264447","title":"PolyPid Files Form 3 Initial Beneficial Ownership Statement for Director Itzhak Krinsky","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264447","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264447?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:03","pubTimestamp":1773864236,"startTime":"0","endTime":"0","summary":"PolyPid reported an initial statement of beneficial ownership by director Itzhak Krinsky. Krinsky reported direct ownership of 833 ordinary shares. Krinsky also reported stock options covering 22,460 ordinary shares, with exercise prices of USD 2.67 and USD 23.07.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9whZsD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2620264466","title":"PolyPid Deputy CEO Dalit Fellous Hazan Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264466","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264466?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:03","pubTimestamp":1773864180,"startTime":"0","endTime":"0","summary":"PolyPid filed an initial statement of beneficial ownership naming Dalit Hazan Fellous as an officer. The filing lists her title as Deputy CEO. It also identifies her as EVP, RD, CRA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3734d9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2620475735","title":"Roth MKM Reaffirms Their Buy Rating on PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620475735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620475735?lang=en_us&edition=fundamental","pubTime":"2026-03-17 22:55","pubTimestamp":1773759306,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on PolyPid today and set a price target of $9.00. Pachaiyappan covers the Healthcare...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"gpt_icon":0},{"id":"2620422899","title":"BRIEF-Polypid Receives PDUFA Fee Waiver From FDA For D-Plex₁₀₀’S New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422899?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:31","pubTimestamp":1773750711,"startTime":"0","endTime":"0","summary":"BRIEF-Polypid Receives PDUFA Fee WaiverFrom FDA For D-Plex’S New Drug ApplicationMarch 17 (Reuters) - PolyPid Ltd PYPD.O:POLYPID RECEIVES PDUFA FEE WAIVER FROM FDA FOR D-PLEX’S NEW DRUG APPLICATIONPOL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUALMBKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2620247014","title":"PolyPid Receives Pdufa Fee Waiver From FDA for D-Plex₁₀₀’S New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247014?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:30","pubTimestamp":1773750602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUALMBKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2620228684","title":"PolyPid Ltd - on Track to Initiate Nda Submission for D-Plex₁₀₀ by End of March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228684?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:30","pubTimestamp":1773750602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUALMBKH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2614554030","title":"PolyPid FY 2025 marketing and business development expense rises to USD 2.0 million (+109.2%)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614554030","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614554030?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:04","pubTimestamp":1772053448,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL503Cxv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2614312080","title":"PolyPid Senior Management to Join Citizens 2026 Life Sciences Conference and 38th Annual ROTH Conference Fireside Chats","url":"https://stock-news.laohu8.com/highlight/detail?id=2614312080","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614312080?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:35","pubTimestamp":1772026511,"startTime":"0","endTime":"0","summary":"PolyPid Senior Management to Join Citizens 2026 Life Sciences Conference and 38th Annual ROTH Conference Fireside Chats               PolyPid Ltd. said senior management will participate in the Citize","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL2y3S6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","PYPD","IE00BGHQF748.EUR","BK4588","LU0314104364.USD","BK4007","BK4112","LU2095319765.USD","IE00BKPKM429.USD","NDAQ","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2614080430","title":"PolyPid Announces Participation in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2614080430","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614080430?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:35","pubTimestamp":1772026500,"startTime":"0","endTime":"0","summary":"PETACH TIKVA,Israel, Feb.  25, 2026  (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by el","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/25/3244614/0/en/PolyPid-Announces-Participation-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","X","BK4006","BK4007","BK4516","BK4520","BK4585","BK4588"],"gpt_icon":0},{"id":"2611163468","title":"Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Dexcom (DXCM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2611163468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611163468?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:31","pubTimestamp":1770993076,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PolyPid (PYPD – Research Report), Dexcom (DXCM – Res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-polypid-pypd-dexcom-dxcm-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-polypid-pypd-dexcom-dxcm-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2211815571.USD","LU1923622614.USD","LU0354030438.USD","DXCM","BLSG","BK4585","PYPD","LU2210150020.SGD","LABU","BK4581","BK4588","LU2433249047.HKD","LU2125909593.SGD","LU0128526141.USD","BK4082","LU2210149790.SGD","BK4504","IE00BMPRXN33.USD","BK4548","LU0266013472.USD","IE00BMPRXR70.SGD","BK4551","LU1323610961.USD","XBI","LU0354030511.USD","BK4007","LU2125909247.SGD","BK4112","LU2095319765.USD","BK4534","BK4137","LU0029874061.USD","BLSX"],"gpt_icon":0},{"id":"2610998962","title":"PolyPid Earnings Call Flags Big 2026 Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2610998962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610998962?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:19","pubTimestamp":1770855570,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. (($PYPD)) has held its Q4 earnings call. Read on for the main highlights of the call. PolyPid’s latest earnings call struck an upbeat ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-earnings-call-flags-big-2026-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-earnings-call-flags-big-2026-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"gpt_icon":0},{"id":"2610950036","title":"PolyPid Price Target Maintained With a $13.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2610950036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610950036?lang=en_us&edition=fundamental","pubTime":"2026-02-12 02:26","pubTimestamp":1770834360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYPD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2026 13:26 ET (18:26 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"gpt_icon":0},{"id":"2610973954","title":"PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2610973954","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610973954?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:05","pubTimestamp":1770825935,"startTime":"0","endTime":"0","summary":"In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on PolyPid, with a price target of $13.00. Brandon Folkes h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/polypid-advancing-d-plex100-de-risks-platform-potential-and-creates-compelling-buy-rated-risk-reward-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/polypid-advancing-d-plex100-de-risks-platform-potential-and-creates-compelling-buy-rated-risk-reward-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2610932012","title":"Israel's PolyPid Q4 EPS improves on lower R&D expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932012","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932012?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:38","pubTimestamp":1770813539,"startTime":"0","endTime":"0","summary":"Israel's PolyPid Q4 EPS improves on lower R&D expensesOverviewIsrael biopharmaceutical firm's Q4 net loss was $8.5 mln, with improved loss per shareR&D expenses decreased due to completion of SHIELD I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL1N3Z70LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2610932223","title":"BRIEF-PolyPid Q4 Net Income USD -8.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932223","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932223?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813046,"startTime":"0","endTime":"0","summary":"BRIEF-PolyPid Q4 Net Income USD -8.5 Million\n\n\nFeb 11 (Reuters) - PolyPid Q4 EPS USD -0.41.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nPLX1C4134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2610932276","title":"PolyPid posts FY2025 net loss of USD 8.47 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932276?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813042,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. reported its financial results for the fourth quarter  and full year  ended December 31, 2025. For FY 2025, the company reported a net loss attributable to ordinary shares of USD 8.47 million. The loss per share for the period was USD 0.41, based on a weighted average of 20,588,114 ordinary shares. In Q4 2025, PolyPid recorded an operating loss of USD 8.53 million and a net financial expense of USD 24 thousand. The company also posted a loss before income tax of USD 8.55 million for the full year. General and administrative expenses for FY 2025 amounted to USD 1.76 million, while marketing and business development expenses were USD 556 thousand. On the business front, PolyPid is in advanced discussions regarding a commercial U.S. partnership for its lead product, D-PLEX100. The company received positive FDA pre-NDA feedback supporting a rolling NDA review, with the submission expected to begin by the end of the first quarter of 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL902QCw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014039.USD","BK4007","SG9999014013.SGD","LU0314104364.USD","NDAQ","LU2095319765.USD","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","PYPD","BK4112","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2610200932","title":"PolyPid Q4 EPS $(0.41) Misses $(0.34) Estimate.","url":"https://stock-news.laohu8.com/highlight/detail?id=2610200932","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610200932?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813041,"startTime":"0","endTime":"0","summary":"PolyPid (NASDAQ:PYPD) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.34) by 21.66 percent. This is a 63.72 percent increase over losses of $(1.13) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50537532/polypid-q4-eps-0-41-misses-0-34-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polypid.com","stockEarnings":[{"period":"1week","weight":-0.0568},{"period":"1month","weight":-0.0072},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.2029},{"period":"1year","weight":0.4769},{"period":"ytd","weight":-0.0438}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.080091},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.020861},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.077912},{"month":4,"riseRate":0.6,"avgChangeRate":-0.021004},{"month":5,"riseRate":0.4,"avgChangeRate":-0.000865},{"month":6,"riseRate":0.2,"avgChangeRate":-0.006444},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.076054},{"month":8,"riseRate":0.333333,"avgChangeRate":0.004327},{"month":9,"riseRate":0,"avgChangeRate":-0.267226},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.05946},{"month":11,"riseRate":0.666667,"avgChangeRate":0.027739},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.103805}],"exchange":"NASDAQ","name":"PolyPid Ltd.","nameEN":"PolyPid Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PolyPid Ltd.,PYPD,PolyPid Ltd.股票,PolyPid Ltd.股票老虎,PolyPid Ltd.股票老虎国际,PolyPid Ltd.行情,PolyPid Ltd.股票行情,PolyPid Ltd.股价,PolyPid Ltd.股市,PolyPid Ltd.股票价格,PolyPid Ltd.股票交易,PolyPid Ltd.股票购买,PolyPid Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction